60 , 588594 (1993) Lewn, A., Matz, P
What side effects should I expect when starting GLP-1/GIP weight loss therapy
The effect of glucagon-like peptide-1 (GLP-1) receptor agonists in persons with obesity and knee osteoarthritis in this population has not been well-established. To test the impact of a GLP-1 receptor weight loss medication on knee OA outcomes, Bliddal and colleagues conducted a double-blind, randomized, placebo-controlled trial at 61 sites across 11 countries
Nasal Spray Melanotan I is a synthetic research peptide analogue of alpha-melanocyte-stimulating hormone, commonly studied in relation to melanocortin receptor pathways, pigmentation signalling, and intranasal delivery research models
We work with industry-leaders, top researchers, and consultants to build content roadmaps that are then structured into courses, filmed, and edited by our production team before being launched to our site
Limitations Direct trial evidence is in HIV-associated populations